Spero Therapeutics, Inc.
SPRO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $53 | $76 | $109 | $113 |
| Short-Term Investments | $0 | $0 | $0 | $34 |
| Receivables | $52 | $51 | $1 | $3 |
| Inventory | $0 | $0 | -$4 | $0 |
| Other Curr. Assets | $2 | $4 | $3 | $9 |
| Total Curr. Assets | $107 | $131 | $109 | $158 |
| Property Plant & Equip (Net) | $3 | $4 | $5 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $47 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $10 | $6 |
| Total NC Assets | $3 | $51 | $16 | $13 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $111 | $182 | $125 | $171 |
| Liabilities | – | – | – | – |
| Payables | $7 | $1 | $1 | $1 |
| Short-Term Debt | $2 | $2 | $2 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $22 | $27 | $10 | $2 |
| Other Curr. Liab. | $18 | $7 | $9 | $14 |
| Total Curr. Liab. | $49 | $37 | $22 | $19 |
| LT Debt | $3 | $4 | $5 | $6 |
| Deferred Rev, NC | $12 | $34 | $22 | $9 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $0 | $0 | $49 |
| Total NC Liab. | $15 | $38 | $27 | $64 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $4 | $7 | $7 |
| Total Liabilities | $64 | $75 | $49 | $83 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$460 | -$391 | -$414 | -$367 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $506 | $498 | $490 | $456 |
| Total Equity | $46 | $107 | $76 | $88 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $111 | $182 | $125 | $171 |
| Net Debt | -$49 | -$71 | -$102 | -$105 |